Arecor Therapeutics Statistics
Total Valuation
AIM:AREC has a market cap or net worth of GBP 27.00 million. The enterprise value is 25.28 million.
| Market Cap | 27.00M |
| Enterprise Value | 25.28M |
Important Dates
The next estimated earnings date is Wednesday, December 24, 2025.
| Earnings Date | Dec 24, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AIM:AREC has 37.76 million shares outstanding. The number of shares has increased by 20.83% in one year.
| Current Share Class | 37.76M |
| Shares Outstanding | 37.76M |
| Shares Change (YoY) | +20.83% |
| Shares Change (QoQ) | +4.15% |
| Owned by Insiders (%) | 12.13% |
| Owned by Institutions (%) | 51.14% |
| Float | 22.71M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.33 |
| PB Ratio | 9.45 |
| P/TBV Ratio | 9.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.12 |
| EV / Sales | 5.00 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -4.06 |
Financial Position
The company has a current ratio of 2.05, with a Debt / Equity ratio of 0.06.
| Current Ratio | 2.05 |
| Quick Ratio | 2.00 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.03 |
| Interest Coverage | -308.06 |
Financial Efficiency
Return on equity (ROE) is -204.29% and return on invested capital (ROIC) is -82.64%.
| Return on Equity (ROE) | -204.29% |
| Return on Assets (ROA) | -44.39% |
| Return on Invested Capital (ROIC) | -82.64% |
| Return on Capital Employed (ROCE) | -189.64% |
| Revenue Per Employee | 115,023 |
| Profits Per Employee | -184,182 |
| Employee Count | 44 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 12.39 |
Taxes
| Income Tax | -265,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.14% in the last 52 weeks. The beta is -0.28, so AIM:AREC's price volatility has been lower than the market average.
| Beta (5Y) | -0.28 |
| 52-Week Price Change | -7.14% |
| 50-Day Moving Average | 73.37 |
| 200-Day Moving Average | 54.57 |
| Relative Strength Index (RSI) | 39.78 |
| Average Volume (20 Days) | 30,102 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AIM:AREC had revenue of GBP 5.06 million and -8.10 million in losses. Loss per share was -0.22.
| Revenue | 5.06M |
| Gross Profit | 1.60M |
| Operating Income | -5.55M |
| Pretax Income | -8.37M |
| Net Income | -8.10M |
| EBITDA | -5.35M |
| EBIT | -5.55M |
| Loss Per Share | -0.22 |
Balance Sheet
The company has 1.89 million in cash and 173,000 in debt, giving a net cash position of 1.71 million or 0.05 per share.
| Cash & Cash Equivalents | 1.89M |
| Total Debt | 173,000 |
| Net Cash | 1.71M |
| Net Cash Per Share | 0.05 |
| Equity (Book Value) | 2.86M |
| Book Value Per Share | 0.08 |
| Working Capital | 2.45M |
Cash Flow
In the last 12 months, operating cash flow was -6.12 million and capital expenditures -106,000, giving a free cash flow of -6.22 million.
| Operating Cash Flow | -6.12M |
| Capital Expenditures | -106,000 |
| Free Cash Flow | -6.22M |
| FCF Per Share | -0.16 |
Margins
Gross margin is 31.67%, with operating and profit margins of -109.56% and -160.13%.
| Gross Margin | 31.67% |
| Operating Margin | -109.56% |
| Pretax Margin | -165.36% |
| Profit Margin | -160.13% |
| EBITDA Margin | -105.65% |
| EBIT Margin | -109.56% |
| FCF Margin | n/a |
Dividends & Yields
AIM:AREC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -20.83% |
| Shareholder Yield | -20.83% |
| Earnings Yield | -30.02% |
| FCF Yield | -23.05% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AIM:AREC has an Altman Z-Score of -8.54 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -8.54 |
| Piotroski F-Score | 3 |